Abstract
BackgroundCardiovascular autonomic neuropathy (CAN) is the commonest risk predictor for sudden cardiac death in autoimmune rheumatic diseases.1-2 As yet, there is no therapeutic treatment of cardiovascular autonomic neuropathy in psoriatic...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
